Axol Bioscience
Axol Bioscience are human cell culture specialists, providing primary cells and iPSC derived cells with a wide range of functionally and physiologically, disease relevant backgrounds, together with optimised media and growth supplements.
Cambridge, UKwww.axolbio.com ↗
Total raised
€6.2M
€6,243,533
Funding rounds
2
Investors
7
distinct backers
Active since
2022-04
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood16
base rate 30% for Other
- ▼ Raised very recently
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-15 | Other | €2.4M | BroadOak Capital Partners,Roslin Foundation | View deal → |
| 2022-04-08 | Other | €3.8M | Calculus Capital,Dr Jonathan Milner,Meltwind,Par Equity,Scottish Enterprise | View deal → |